Abiopharma

HOULIHAN LOKEY, INC. (HLI)

Symbol	HLI
Name	HOULIHAN LOKEY, INC.
Sector	FINANCE
Region	North America
Industry	Investment Advice
Address	HOULIHAN LOKEY, INC., LOS ANGELES, CA 90067
Telephone	310.553.8871
Fax	—
Email	—
Website	https://www.hl.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001302215
Description	Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States. Additional info from NASDAQ: Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.

2026-05-11 14:00

Houlihan Lokey Grows Global Technology Group With Experienced Hire

2026-05-06 20:40

Houlihan Lokey Reports Fiscal Year and Fourth Quarter 2026 Financial Results

2026-04-30 11:24

New Form SCHEDULE 13G - HOULIHAN LOKEY, INC. Filed: 2026-04-30 AccNo: 0002100119-26-000578 Size: 7 KB

2026-04-29 14:38

New Form SCHEDULE 13G - HOULIHAN LOKEY, INC. Filed: 2026-04-29 AccNo: 0002100121-26-000341 Size: 7 KB

2026-04-15 20:15

Houlihan Lokey Announces Release Date for Fourth Quarter and Full Year Results for Fiscal Year 2026

2026-04-02 22:32

CRAIN CHRISTOPHER M 🟡 adjusted position in 51.7K shares (2 derivative) of HOULIHAN LOKEY, INC. (HLI) at $143.40 Transaction Date: Apr 01, 2026 | Filing ID: 000011

2026-04-01 20:44

📋 CHRISTOPHER MADISON CRAIN (Officer) plans to sell 500 shares of Houlihan Lokey, Inc. (at $143.62 each, total $72K) Filed: Apr 01, 2026 | ID: 003160

2026-03-27 10:35

New Form SCHEDULE 13G/A - HOULIHAN LOKEY, INC. Filed: 2026-03-27 AccNo: 0000102909-26-001495 Size: 7 KB

2026-03-23 14:00

Houlihan Lokey Strengthens Capital Solutions Group With Senior Real Estate Hire